Ferring Pharmaceuticals A/S

4 products tracked · names used in filings: Ferring Pharmaceuticals A/S

Upcoming milestones

No upcoming milestones listed.

Recent milestones

Thu 28 May 2026🇪🇺 EU approval (EC decision)

Adstiladrin (nadofaragene firadenovec) approved in the EU

Marketing authorisation to Ferring Pharmaceuticals A/S; ATMP, Conditional, Additional monitoring · source

Thu 26 Mar 2026🇪🇺 CHMP positive opinion

Adstiladrin (nadofaragene firadenovec): CHMP positive opinion

Ferring Pharmaceuticals A/S; ATMP, Conditional, Additional monitoring · source

Products

ProductStatusApproved
🇪🇺Adstiladrin
nadofaragene firadenovec		Authorised2026-05-28
🇪🇺Rekovelle
follitropin delta		Authorised2016-12-12
🇪🇺Firmagon
degarelix		Authorised2009-02-17
🇪🇺Tractocile
atosiban		Authorised2000-01-20

Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.